Prostaglandin E and cancer Growth

James Goodwin, G. Husby, R. C. Williams

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

This paper reviews the evidence linking prostaglandin E (PGE) with the growth of neoplastic tissue. PGE2 is present in high concentrations in many natural and experimentally produced cancers. The immunosuppressive effect of some tumors in mice is due at least in part to a prostaglandin mechanism. The growth of these same tumors can be slowed and in some cases the tumor eliminated by administration of PG synthetase inhibitors. It is not yet clear whether the antitumor properties of these PG synthetase inhibitors are due to their releasing the hostimmune system from the chronic prostaglandin-mediated suppression of the tumor, resulting in an effective immune response to the tumor, or whether another mechanism is responsible. In humans overproduction of PGE2 by macrophages is partly responsible for the depressed PHA response in patients with Hodgkin's disease.

Original languageEnglish (US)
Pages (from-to)3-7
Number of pages5
JournalCancer Immunology Immunotherapy
Volume8
Issue number1
DOIs
StatePublished - Apr 1980
Externally publishedYes

Fingerprint

Prostaglandins E
Growth
Neoplasms
Ligases
Dinoprostone
Prostaglandins
Immunosuppressive Agents
Hodgkin Disease
Macrophages

ASJC Scopus subject areas

  • Oncology
  • Immunology
  • Cancer Research

Cite this

Prostaglandin E and cancer Growth. / Goodwin, James; Husby, G.; Williams, R. C.

In: Cancer Immunology Immunotherapy, Vol. 8, No. 1, 04.1980, p. 3-7.

Research output: Contribution to journalArticle

Goodwin, James ; Husby, G. ; Williams, R. C. / Prostaglandin E and cancer Growth. In: Cancer Immunology Immunotherapy. 1980 ; Vol. 8, No. 1. pp. 3-7.
@article{fd1dae2b39e54cb0adb7bc7e13633851,
title = "Prostaglandin E and cancer Growth",
abstract = "This paper reviews the evidence linking prostaglandin E (PGE) with the growth of neoplastic tissue. PGE2 is present in high concentrations in many natural and experimentally produced cancers. The immunosuppressive effect of some tumors in mice is due at least in part to a prostaglandin mechanism. The growth of these same tumors can be slowed and in some cases the tumor eliminated by administration of PG synthetase inhibitors. It is not yet clear whether the antitumor properties of these PG synthetase inhibitors are due to their releasing the hostimmune system from the chronic prostaglandin-mediated suppression of the tumor, resulting in an effective immune response to the tumor, or whether another mechanism is responsible. In humans overproduction of PGE2 by macrophages is partly responsible for the depressed PHA response in patients with Hodgkin's disease.",
author = "James Goodwin and G. Husby and Williams, {R. C.}",
year = "1980",
month = "4",
doi = "10.1007/BF00206347",
language = "English (US)",
volume = "8",
pages = "3--7",
journal = "Cancer Immunology and Immunotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "1",

}

TY - JOUR

T1 - Prostaglandin E and cancer Growth

AU - Goodwin, James

AU - Husby, G.

AU - Williams, R. C.

PY - 1980/4

Y1 - 1980/4

N2 - This paper reviews the evidence linking prostaglandin E (PGE) with the growth of neoplastic tissue. PGE2 is present in high concentrations in many natural and experimentally produced cancers. The immunosuppressive effect of some tumors in mice is due at least in part to a prostaglandin mechanism. The growth of these same tumors can be slowed and in some cases the tumor eliminated by administration of PG synthetase inhibitors. It is not yet clear whether the antitumor properties of these PG synthetase inhibitors are due to their releasing the hostimmune system from the chronic prostaglandin-mediated suppression of the tumor, resulting in an effective immune response to the tumor, or whether another mechanism is responsible. In humans overproduction of PGE2 by macrophages is partly responsible for the depressed PHA response in patients with Hodgkin's disease.

AB - This paper reviews the evidence linking prostaglandin E (PGE) with the growth of neoplastic tissue. PGE2 is present in high concentrations in many natural and experimentally produced cancers. The immunosuppressive effect of some tumors in mice is due at least in part to a prostaglandin mechanism. The growth of these same tumors can be slowed and in some cases the tumor eliminated by administration of PG synthetase inhibitors. It is not yet clear whether the antitumor properties of these PG synthetase inhibitors are due to their releasing the hostimmune system from the chronic prostaglandin-mediated suppression of the tumor, resulting in an effective immune response to the tumor, or whether another mechanism is responsible. In humans overproduction of PGE2 by macrophages is partly responsible for the depressed PHA response in patients with Hodgkin's disease.

UR - http://www.scopus.com/inward/record.url?scp=0018827339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018827339&partnerID=8YFLogxK

U2 - 10.1007/BF00206347

DO - 10.1007/BF00206347

M3 - Article

AN - SCOPUS:0018827339

VL - 8

SP - 3

EP - 7

JO - Cancer Immunology and Immunotherapy

JF - Cancer Immunology and Immunotherapy

SN - 0340-7004

IS - 1

ER -